{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:07:46Z","timestamp":1772165266730,"version":"3.50.1"},"reference-count":24,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,13]]},"DOI":"10.1182\/bloodadvances.2022009061","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T16:43:52Z","timestamp":1674060232000},"page":"2558-2563","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Genomics of PDGFR-rearranged hypereosinophilic syndrome"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5566-6729","authenticated-orcid":false,"given":"Esther","family":"Rheinbay","sequence":"first","affiliation":[{"name":"1Broad Institute of Harvard and MIT, Cambridge, MA"},{"name":"2Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8671-3110","authenticated-orcid":false,"given":"Meifang","family":"Qi","sequence":"additional","affiliation":[{"name":"1Broad Institute of Harvard and MIT, Cambridge, MA"},{"name":"2Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette M.","family":"Bouyssou","sequence":"additional","affiliation":[{"name":"3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6310-0434","authenticated-orcid":false,"given":"Andrew J.","family":"Oler","sequence":"additional","affiliation":[{"name":"4Bioinformatics and Computational Biosciences Branch, Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Thumm","sequence":"additional","affiliation":[{"name":"5Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5673-3815","authenticated-orcid":false,"given":"Michelle","family":"Makiya","sequence":"additional","affiliation":[{"name":"6Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Maric","sequence":"additional","affiliation":[{"name":"6Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4986-5326","authenticated-orcid":false,"given":"Amy D.","family":"Klion","sequence":"additional","affiliation":[{"name":"6Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7380-0226","authenticated-orcid":false,"given":"Andrew A.","family":"Lane","sequence":"additional","affiliation":[{"name":"1Broad Institute of Harvard and MIT, Cambridge, MA"},{"name":"3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"issue":"11","key":"2023061316230072600_bib1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute aeukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"2023061316230072600_bib2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"2023061316230072600_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajh.26352","article-title":"World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Shomali","year":"2022","journal-title":"Am J Hematol"},{"issue":"9","key":"2023061316230072600_bib4","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","article-title":"CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy","volume":"102","author":"Pardanani","year":"2003","journal-title":"Blood"},{"issue":"13","key":"2023061316230072600_bib5","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A\u00a0tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"2023061316230072600_bib6","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","article-title":"Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness","volume":"101","author":"Klion","year":"2003","journal-title":"Blood"},{"issue":"11","key":"2023061316230072600_bib7","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ajh.25945","article-title":"Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: data from 151 patients","volume":"95","author":"Rohmer","year":"2020","journal-title":"Am J Hematol"},{"issue":"3","key":"2023061316230072600_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"2023061316230072600_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/all.15544","article-title":"Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes","volume":"78","author":"Valent","year":"2023","journal-title":"Allergy"},{"issue":"3","key":"2023061316230072600_bib10","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1002\/ajh.24273","article-title":"Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation","volume":"91","author":"Pardanani","year":"2016","journal-title":"Am J Hematol"},{"issue":"9","key":"2023061316230072600_bib25","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1101\/gr.092759.109","article-title":"Circos: an information aesthetic for comparative genomics","volume":"19","author":"Krzywinski","year":"2009","journal-title":"Genome Res"},{"issue":"6","key":"2023061316230072600_bib11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/blood-2016-10-695973","article-title":"Myeloid neoplasms with eosinophilia","volume":"129","author":"Reiter","year":"2017","journal-title":"Blood"},{"issue":"7793","key":"2023061316230072600_bib12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","journal-title":"Nature"},{"issue":"7793","key":"2023061316230072600_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"issue":"7463","key":"2023061316230072600_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"2023061316230072600_bib15","first-page":"508127","article-title":"Comprehensive analysis of tumour initiation, spatial and temporal progression under multiple lines of treatment","author":"Leshchiner","year":"2019","journal-title":"bioRxiv"},{"issue":"11","key":"2023061316230072600_bib16","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1038\/s41375-021-01200-w","article-title":"Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies","volume":"35","author":"Decker","year":"2021","journal-title":"Leukemia"},{"issue":"15","key":"2023061316230072600_bib17","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1158\/1078-0432.CCR-14-2203","article-title":"Biological activities of RUNX1 mutants predict secondary acute leukemia transformation from chronic myelomonocytic leukemia and myelodysplastic syndromes","volume":"21","author":"Tsai","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"7793","key":"2023061316230072600_bib18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","article-title":"Analyses of non-coding somatic drivers in 2,658 cancer whole genomes","volume":"578","author":"Rheinbay","year":"2020","journal-title":"Nature"},{"issue":"26","key":"2023061316230072600_bib20","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"2023061316230072600_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ng.3726","article-title":"Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias","volume":"49","author":"Dunford","year":"2017","journal-title":"Nat Genet"},{"issue":"2","key":"2023061316230072600_bib22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1158\/2159-8290.CD-20-1513","article-title":"Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis","volume":"12","author":"Togami","year":"2022","journal-title":"Cancer Discov"},{"issue":"21","key":"2023061316230072600_bib23","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1158\/1078-0432.CCR-20-1741","article-title":"X- and Y-linked chromatin-modifying genes as regulators of sex-specific cancer incidence and prognosis","volume":"26","author":"Tricarico","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2023061316230072600_bib24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/ng.2966","article-title":"Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer","volume":"46","author":"Forsberg","year":"2014","journal-title":"Nat Genet"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/11\/2558\/2056837\/blooda_adv-2022-009061-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/11\/2558\/2056837\/blooda_adv-2022-009061-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T12:23:32Z","timestamp":1686659012000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/11\/2558\/494140\/Genomics-of-PDGFR-rearranged-hypereosinophilic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,6,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022009061","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.09.19.508443","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]}}}